Brief: Lava Therapeutics Reports Q1 2023 Results

LAVA Therapeutics NV

08/06/2023 13:22

June 8 (Reuters) - Lava Therapeutics Nv  LVTX.O :
    * LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
    * STRONG BALANCE SHEET EXPECTED TO PROVIDE CASH RUNWAY INTO
2026
    * AS OF MARCH 31, 2023, LAVA HAD CASH, CASH EQUIVALENTS AND
INVESTMENTS TOTALING $125.4 MILLION
    * QTRLY NET LOSS PER SHARE $0.53
    * Q1 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXjY3Gh 
Further company coverage:  LVTX.O